Investors Buy Large Volume of Evelo Biosciences Put Options (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) saw some unusual options trading activity on Wednesday. Traders purchased 1,885 put options on the stock. This is an increase of approximately 1,101% compared to the typical daily volume of 157 put options.

Evelo Biosciences Stock Performance

The company has a 50-day simple moving average of $0.03 and a 200 day simple moving average of $0.04. The company has a market capitalization of $2,000.00, a price-to-earnings ratio of 0.00 and a beta of 1.58. Evelo Biosciences has a 12-month low of $0.00 and a 12-month high of $7.69.

Evelo Biosciences Company Profile

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.